Professor Carlo-Federico Perno is currently Professor of Microbiology at UniCamillus International Medical University in Rome, and Director of Microbiology at IRCCS Bambino Gesu’ Pediatric Hospital in Rome
He also works as consultant of Clinical Virology at the Spallanzani Hospital for Infectious Diseases, Rome.
Until June 2020 he was Professor of Microbiology at the University of Rome Tor Vergata, and then at the University of Milan, Italy. Until June 2020 he was also Director of the Department of Laboratory Medicine at the Niguarda Hospital in Milan.
Professor Perno gained his MD from the University of Rome in 1980, and graduated in oncology in 1983. From 1986 to 1989 he worked as Research Fellow at the National Cancer Institute, Bethesda, Maryland, USA, where he collaborated to the discovery and clinical application of the first antiviral drugs used in the therapy of HIV infection, including AZT, ddC, d4T and ddI.
Professor Perno published about 600 scientific articles (H index 68, Impact Factor >2,500), including peer reviewed articles in high rank journals (Nature, Science, Lancet, J Experimental Medicine, PNAS, etc), mostly dedicated to microbiology and antiviral therapy.
In 2001 the European Community awarded him the Descartes Award for excellence in the antiviral field.
From 2013 up today he is President of the Scientific Council at CIRCB, Center of International Research Chantal Biya, Yaoundè, Cameroon.
He has a major expertise in antimicrobial resistance and antiviral therapy. He leads a group of internationally recognised researchers funded by numerous grants from Italian institutions, European Community, and private institutions.